Evidence map›Paper›PMID 32545905›Full record

ArticleInternational journal of molecular sciences2020

Endoplasmic Reticulum Associated Degradation of Spinocerebellar Ataxia-Related CD10 Cysteine Mutant.

Mai Kanuka, Fuka Ouchi, Nagisa Kato, Riko Katsuki, Saori Ito, Kohta Miura, Masaki Hikida, Taku Tamura

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mai KanukaDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Fuka OuchiDepartment of Life Science, Faculty of Engineering Science, Akita University, Akita 010-8502, Japan.
Nagisa KatoDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Riko KatsukiDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Saori ItoDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Kohta MiuraDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Masaki HikidaDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.
Taku TamuraDepartment of Life Science, Graduate school of Engineering and Resource, Akita University, Akita 010-8502, Japan.ORCID 0000-0001-6074-9273
Akita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar ataxia (SCA) is one of the most severe neurodegenerative diseases and is often associated with misfolded protein aggregates derived from the genetic mutation of related genes. Recently, mutations in CD10 such as C143Y have been identified as SCA type 43. CD10, also known as neprilysin or neuroendopeptidase, digests functional neuropeptides, such as amyloid beta, in the extracellular region. In this study, we explored the cellular behavior of CD10 C143Y to gain an insight into the functional relationship of the mutation and SCA pathology. We found that wild-type CD10 is expressed on the plasma membrane and exhibits endopeptidase activity in a cultured cell line. CD10 C143Y, however, forms a disulfide bond-mediated oligomer that does not appear by the wild-type CD10. Furthermore, the CD10 C143Y mutant was retained in the endoplasmic reticulum (ER) by the molecular chaperone BiP and was degraded through the ER-associated degradation (ERAD) process, in which representative ERAD factors including EDEM1, SEL1L, and Hrd1 participate in the degradation. Suppression of CD10 C143Y ERAD recovers intracellular transport but not enzymatic activity. Our results indicate that the C143Y mutation in CD10 negatively affects protein maturation and results in ER retention and following ERAD. These findings provide beneficial insight into SCA type 43 pathology.

Indexed as

MutationCell MembraneCysteineDisulfidesEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHeLa CellsHumansNeprilysinOligopeptidesProteolysisSpinocerebellar AtaxiasBax-inhibiting peptide, BIPCysteineDisulfidesNeprilysinOligopeptidesCD10disulfide bondendoplasmic reticulum-associated degradation (ERAD)ER quality controlspinocerebellar ataxia

Identifiers

PMID32545905
PMCPMC7352294
OpenAlexW3034496401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.